Skip to main content
INMB
NASDAQ Life Sciences

UK MHRA Aligns with INmune Bio on Ebstrocel Conditional MAA, Paving Way for 2026 Submission

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.42
Mkt Cap
$37.751M
52W Low
$1.09
52W High
$11.64
52W Position info
30% above low
Off High info
88% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

INMB sits 30% above its 52-week low of $1.09.

Summary

INmune Bio received positive alignment from the UK's MHRA for its planned 2026 conditional Marketing Authorization Application (MAA) for Ebstrocel (CORDStrom™) in RDEB. The MHRA confirmed agreement on CMC, non-clinical, and clinical evidence packages, providing a clear regulatory path. This news follows an 8-K filed minutes earlier today disclosing the same positive regulatory feedback. This is a crucial step towards potential commercialization in the UK for Ebstrocel, offering a clearer path to market for one of its key drug candidates. For a small biotech company with a going concern warning, securing regulatory alignment significantly de-risks the development pathway and provides a potential revenue stream. The company plans to submit the conditional MAA in 2026.

At the time of this announcement, INMB was trading at $1.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.8M. The 52-week trading range was $1.09 to $11.64. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

INMB - Latest Insights

INMB
Nov 05, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.18
Real-time Price: $0.960 info
Change: -$0.215 (-18%) info
Market Cap: $29.721M info
INMB
Oct 29, 2026, 7:30 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.52
Real-time Price: $0.960 info
Change: -$0.560 (-37%) info
Market Cap: $29.721M info
INMB
Oct 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.41
Real-time Price: $0.960 info
Change: -$0.450 (-32%) info
Market Cap: $29.721M info
INMB
Oct 21, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $0.960 info
Change: -$0.729 (-43%) info
Market Cap: $29.721M info
INMB
Oct 21, 2026, 7:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $0.960 info
Change: -$0.670 (-41%) info
Market Cap: $29.721M info